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Abstract – MHC-related protein 1 (MR1) is a highly conserved MHC class I-like molecule. Human and
murine mucosal associated invariant T (MAIT) cells are restricted by MR1 and express an invariant T cell
receptor. Even though MR1 protein expression on the cell surface has not been demonstrated in vivo or
ex vivo, it is assumed that MR1 presents a bacterial antigen from the intestinal lumen to MAITcells because
MAIT cells are present in the lamina propria and their expansion is dependent on the presence of intestinal
micro ﬂora. The existence of bovine MAIT cells and MR1 has been demonstrated recently although ovine
MAIT cells and MR1 have not yet been described. We cloned bovine and ovine MR1 transcripts, including
splice variants, and identiﬁed an anti human MR1 antibody that recognizes cells transfected with the bovine
homolog. Using this antibody, no MR1 staining was detected using cells freshly isolated from blood,
thymus, spleen, colon, ileum, and lymph node. MAIT cells are known to be enriched in the CD4/CD8
double negative peripheral blood T cell population, but their relative abundance in different tissues is not
known. Comparison of the amount of MAIT cell-speciﬁc TCR transcript to the amount of constant a chain
transcript revealed that numbers of MAIT cells are low in neonates and increase by 3-weeks of age. In
3-month old animals, MAITcells are abundant in spleen and less so in ileum, peripheral blood, lymph node,
colon, and thymus.
MR1 / ruminant / T cell receptor / mucosal immunology / non-classical MHC
1. INTRODUCTION
MHC class I-like molecules form a group of
proteins that share structural features, notably
the characteristic MHC class I protein fold of
the heavy chain and an ability to associate with
b2-microglobulin. The human MHC region on
chromosome 6 encodes classical and non-
classical MHC class I-like proteins, but other
non-classical classI-like proteins such as human
CD1 and MHC-related protein 1 (MR1) are
located outside the MHC region [3, 14]a t
chromosome 1q23 and 1q25 respectively [15].
Comparison of human and murine MR1
sequences has shown that the a1a n da2
domains, which form the ligand binding part of
MHC class I molecules, have the highest level
of evolutionary conservation among all class
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Article published by EDP SciencesI-related molecules [22]. However, the nature of
the antigen bound to MR1 and how it is pre-
sented to Tcells remain unclear. It has been sug-
gested that, like CD1, MR1 presents lipid
antigens [12, 16],but based on structuralpredic-
tions others have suggested that hydrophilic
antigens like proteins are more likely candidates
[5, 6].
AlthoughMR1transcriptshavebeendetected
in all murine tissues examined, and in a range of
human cell lines [14], cell surface expression of
MR1 protein has not been detected in vivo or
ex vivo [2, 5, 11, 24]. In transfected P388 and
L cell lines, MR1 protein is produced, but is
retained intracellularly [11, 24]. However,
human Hela cells and B6/WT-3 cells transduced
withMR1expressthemoleculeatthecellsurface
[5,11], where itexists in openand folded conﬁg-
urations that are suggestive of empty and anti-
gen-bound forms respectively. MR1 protein
produced in Escherichia coli fails to refold, pos-
sibly because of a lack of ligand [11]. Based on
theseobservations,ithasbeensuggestedthatcell
surface expression of MR1 is tightly regulated
in vivo, and possibly limited by the availability
of ligand. Despite having a physical structure
similar to MHC class I molecules, studies of
MR1 intracellular transport indicate that, like
CD1d,MR1trafﬁcsthroughtheendosomalpath-
way, where it is thought to acquire antigenic
ligands [6].
Mucosal associated invariant T cells (MAIT
cells) were initially described in humans, mice,
and cattle based on the demonstration of a con-
served TCRa chain rearrangement, expressing
the orthologous TCR variable chain in each
species and a highly conserved CDR3 sequence
[18, 19]. They represented a small subset of ab
T cells that were enriched in the CD4
 CD8
  T
cell population, but were also found in the
CD8
aa+ T cell population in humans, and in
the murine CD4
+ population [18]. In mice,
development of MAIT cells has been shown
to be dependent on MR1, b2M, and an intact
thymus, but independent of TAP, classical
MHC molecules, and CD1. MAITcell develop-
ment has recently been shown to involve an ini-
tial intra-thymic selection, dependent on
expression of MR1 and the presence of a hae-
mopoietic-derived cell-type (not B-cells), giv-
ing rise to low numbers of cells with a naı ¨ve
T cell phenotype [9]. This is then followed by
a phase of peripheral expansion, which is also
dependent on MR1 and on B-cells and the pres-
ence of an intact gut ﬂora, resulting in larger
numbers of MAIT cells with a memory pheno-
type. Initial studies of tissue distribution in
mice, based on measurement of MAIT
TCRa transcripts, indicated that MAIT cells
were most abundant in PBMC and lymph node,
and were not present in the intestinal lamina
propria or in the intra-epithelial lymphocytes
(IEL) [18]. However, a later study demonstrated
relatively large quantities of MAIT TCR tran-
scripts in murine and human intestinal lamina
propria, but not in IEL [19].
In addition to being a selecting element dur-
ing T cell development, MR1 is recognized by
some, but not all, MAIT cell hybridomas in
vitro [19]. These and other ﬁndings indicate that
MAIT cells recognize and respond to antigenic
ligands presented by MR1 [2]. Recent work has
demonstrated cross-reactivity of human and
mouse MAIT cells with the respective MR1
orthologues, suggesting conservation of the
ligands [7]. Upon activation, MAIT cells pro-
duce predominantly IL-4, IFNc, and IL-17,
and this triggers the release of pro-inﬂammatory
cytokines from bystander cells, suggesting the
ability of these cells to play a role in the regu-
lation of inﬂammatory responses [17].
The current study set out to examine tran-
scription and expression of MR1 and the distri-
bution of MAIT cells in cattle and sheep and
make a comparison with data obtained in
humans and mice. The results conﬁrmed that
the MAIT-MR1 system is evolutionarily highly
conserved among mammalian species and pro-
vided new evidence that MAIT cells are abun-
dant in the spleen as well as gut-associated
tissues.
2. MATERIALS AND METHODS
2.1. Cloning and transfection of MR1
Full-length bovine and ovine MR1 cDNA
was cloned from PBMC using primers ‘‘boMR1for’’
50-GGGCTGATGATGCTCCTATTGCC-30 and
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TC-30. Bovine PCR were performed with PFU Turbo
polymerase (Stratagene, La Jolla, CA, USA) accord-
ing to the protocol of the manufacturer under the fol-
lowing cycling conditions: an initial denaturation of
7m i na t9 5 C, followed by 35 cycles of 30 s at
95  C, 45 s at 60  C, 1 min at 72  C, followed by
a ﬁnal elongation step of 7 min at 72  C. Ovine
PCR used PCR master mix (ABgene, Epsom, UK)
and DNA polymerase (Bioline BIOTAQ, London,
UK), with cycling conditions: an initial denaturation
of 10 min at 95  C, followed by 35 cycles of
1m i na t9 5 C, 1 min at 60  C, 1 min at 72  C, fol-
lowed by a ﬁnal elongation step of 10 min at 72  C.
PCR products were cut from an agarose gel, puriﬁed,
and ligated in a Topo4blunt vector (Invitrogen,
Breda, The Netherlands) (bovine) or pGEM-T Easy
vector (Promega, Southhampton, UK) (ovine) for
sequencing and in pcDNA3.1 for transient expression
(bovine). Vector DNA of single colonies was
sequenced by Baseclear (Leiden, The Netherlands)
(bovine) or DBS Genomics (Durham University,
UK) (ovine). For some experiments a second set of
primers, ‘‘boovMR1f’’ 50-CGGAGAGAGCAGTAC
AAG-30 and ‘‘boovMR1r’’ 50-CATATGGGACAGA
GGAGG-30, was used to amplify full-length MR1;
the PCR protocol using these primers was as
described above, except with Tm = 54  C.
2.2. Antibodies and ﬂow cytometry
HEK 293 Tcells were transiently transfected with
bovine MR1 in pcDNA3.1 using Fugene-6 reagent
(Roche, Almere, The Netherlands) according to the
manufacturer’s protocol, and analysed 48 h after
transfection. The following anti human MR1 antibod-
ies were tested for reactivity against bovine MR1:
clone 1, clone 7, clone 17, clone 18, clone 20, clone
24 from the same hybridoma screen [5], kindly pro-
vided by Dr S. Gilﬁllan and Dr M. Cella (Department
of Pathology and Immunology, Washington Univer-
sity School of Medicine, St. Louis, MO, USA),
CC43, which recognizes an unidentiﬁed bovine class
I-like molecule [4], and IL-A19, speciﬁc for classical
bovine MHC class I. The anti-human MR1 antibody
clone 20 was determined to be of the IgG2b isotype.
For surface staining, cells were incubated for 30 min
with unlabeled antibodies at 20 lg/mL in phosphate
buffered saline containing 1% bovine serum albumin
(Sigma-Aldrich, Zwijndrecht, The Netherlands)
(PBS/BSA), followed by a wash and incubation for
30 min with phycoerythrin-labelled goat anti-mouse
IgG2b (Southern Biotechnology Associates,
Birmingham, AL, USA), FITC-labelled goat anti
mouse IgG1 (BD Pharmingen, Breda, The Nether-
lands), or Alexa633-labelled goat anti-mouse Ig
(Molecular Probes, Breda, The Netherlands). For
staining of intracellular plus cell surface molecules,
BD cytoﬁx/cytoperm and BD perm/wash (BD
Pharmingen) were used according to the supplied
protocol. Anti-bovine CD3 MM1A (IgG1), anti-
bovine CD21 gb25a (IgG1), and anti-bovine CD14
MM61A (IgG1) were obtained from VMRD
(VMRD, Pullman, WA, USA).
2.3. Sequence of the bovine and ovine
MAIT cell TCR
Primers(bovine)‘‘I’’50-GCTCTGCAGGAAAAG
GCGTTAAG-30 and‘‘K’’50-TTTCAAAGCTTTTCTC
TACCAGCTTGG-30,and(ovine)‘‘boovUntr3f’’ 5-AG
CGCCTGGTTTGTGGTGTC-30 and ‘‘CorovC3r’’
50-AGGTTAAACCCGACCACCTT-30, were applied
to cDNA from bovine and ovine PBMC respectively,
in PCR reactions using ABgene custom PCR master-
mix and Bioline BIOTAQ DNA polymerase. Cycling
conditions were an initial denaturation of 10 min at
95  C, followed by 35 cycles of 1 min at 95  C,
1m i na t6 0 C, 1 min at 72  C, followed by a ﬁnal
elongation step of 10 min at 72  C. PCR products
were cloned into pGEM-T Easy vector and
s e q u e n c e db yD B SG e n o m i c s .
2.4. Animals, tissue samples and cell lines
Two 3-month old Holstein-Friesian bull calves
(c1438 and c5524) were used to provide cells for
ﬂow cytometry and for extraction of nucleic acid
from PBMC and tissue samples (prescapular lymph
node, ileum, colon, spleen, thymus, and peripheral
blood drawn from the jugular vein). Ovine tissue
samples (prescapular lymph node, mesenteric lymph
node, ileum, colon, spleen, thymus, and peripheral
blood drawn from the jugular vein) were collected
from two 6-month old sheep. Further samples of
bovine tissues (prescapular lymph node, mesenteric
lymph node, rumen wall, ileum, colon, spleen, thy-
mus, and peripheral blood drawn from the jugular
vein) were collected from additional Holstein-
Friesian bull calves either within 24 h of birth (neo-
nate), at 3-weeks of age, or 3-months of age. Calves
kept to 3-weeks of age were also blood-sampled
within 24-h of birth to allow animal-speciﬁc compar-
ison of blood samples. At the time of tissue collection
and blood sampling, these animals showed no clini-
cal signs of disease. PBMC were harvested from
blood using a standard Ficoll density gradient. Single
cell suspensions of tissues from calves c1438 and
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and other bovine tissues were homogenised using
F a s t R N AP r o G r e e nl y s i n gm a t r i xt u b e s( M p b i o ,H i l -
ton, UK) and QIAshredder tubes (Qiagen, Crawley,
UK) to produce tissue lysate from which RNA was
extracted.
Bovine cell lines representing different leukocyte
lineages were derived by in vitro infection of bovine
PBMC with either Theileria annulata or Theileria
parva sporozoites as described previously [1]. The
cell lines were phenotyped using ﬂow cytometry as
B-cell (592TPM, 663TA/B), macrophage (592TAA,
663TA), or T-cell (109TPM: CD8 +; 158TPM:
mixed CD8/cd;9 5 1 T P M :cd).
2.5. Cloning of MAIT TCR and qPCR
for MAIT TCRa chain usage
RNA isolation and cDNA synthesis was per-
formed on 2 · 10
7 cells obtained from each tissue
sample of calves c1438 and c5524. RNAwas isolated
with the Qiagen RNAEasy kit, followed by ﬁrst
strand cDNA synthesis with Multiscribe reverse
transcriptase. RNA was isolated from ovine tissues
and other bovine tissues using RNeasy Protect kit
(Qiagen) and DNase-treated using Promega RQ1
RNase-free DNase. cDNA synthesis was performed
using AMV reverse transcriptase (Promega). To gen-
erate a construct that could be used as a positive con-
trol and to generate standard curved for qPCR, a
bovine primer set ‘‘I’’/‘‘K’’ and an ovine pimer set
‘‘boovUntr3f’’/‘‘CorovC3r’’, designed to anneal to
the V segments that are used by bovine and ovine
MAIT cells and the respective a constant chains,
were used to create 750 bp PCR products. These
were cloned and sequenced to conﬁrm MAIT TCRa
chain.
For the MAIT-cell V-region-speciﬁc qPCR the
following primers/probe were used – Forward:
‘‘boAV19’’ 50-CATTCCTTAGACGCTCTGATGCA
CA-30 [18]; Reverse (bovine):‘‘boAJ33’’50-GCCCCA
GATCCACTGATAGTTGC-30 [18]; Reverse (ovine):
‘‘ovAJ33’’ 50-GCCCCAGATCAACCGATAGTTG
C-30; Probe: ‘‘boAV19’’ FAM-50-TTACCTCCTTC
TGAAGGAACTCCACATGAAAGA-30-BHQ. For
the a chain constant-region-speciﬁc qPCR the fol-
lowing primers/probe were used (1) for bovines
c1438 and c5524 – Forward: ‘‘alpha’’ 50-GATGC
GAATACACCTTCAACG-30;R e v e r s e :‘ ‘ K ’ ’5 0-TT
TCAAAGCTTTTCTCTACCAGCTTGG-30;P r o b e :
‘‘const alpha’’ FAM-50-TCCCTTCGCCTCCAGCT
TGGAAATCT-30-BHQ; (2) for ovine and other
bovine tissues – Forward: ‘‘NGconst-f’’ 50-ACGGGA
TAGTGACTTGGGGAA-30;R e v e r s e :‘ ‘ N G c o n s t - r ’ ’
50-TTTCAAAGCTTTTCTCTACCAGCTTGG-30;
Probe: ‘‘NGconst’’ FAM-50-ACACCTTCAAC-
GAGAACA-30. The location of the primers is
shown in Supplementary Figure 1 available online
at www.vetres.org.
On cDNA from bovines c1438 and c5524, qPCR
wereperformedina25 lLreactionvolumecontaining
600 nM of each primer, 100 nM of the probe, and
10 ng of cDNA in TaqMan Universal PCR Master
Mix (Applied Biosystems, Nieuwerkerk a/d IJssel,
TheNetherlands). Ovine andotherbovineqPCRwere
performed in a 20 lL reaction volume containing
500 nM of each primer, 250 nM of probe, and 3 lg
of cDNA in Taqman Gene Expression Master Mix
(AppliedBiosystems).Bothreactions usedthecycling
conditions:an initial incubation of 2 min at 50  C, an
incubation for 10 min at 95  C ,a n d5 0c y c l e so f1 0s
(ovine 15 s) at 95  Ca n d1m i na t5 3 C.
2.6. Database searches and alignments
A BLAST search was performed in the bovine
genome
1 using the nucleic acid sequence of the a1
and a2 domains of human MR1. The obtained
sequence was used for a BLAST search in the NCBI
databases
2 to identify ovine and bovine MR1 tran-
scripts in the EST databases. The Translate Nucleic
Acid Sequence Tool was used
3 for translation into
amino acids. All alignments and phylogenetic trees
were generated with ClustalW
4.
2.7. Statistical analyses of data
Real-time PCR results were assessed using gen-
eral linear mixed effect models using R version 2.9,
a programming language and software environment
for statistical computing, available from http://
www.r-project.org.
3. RESULTS
3.1. Cloning of bovine and ovine
MR1 transcripts
The bovine MR1 gene ENSBTAG0000000
9924 on chromosome 16 is available at www.
ensembl.org/Bos_taurus, version Btau_4.0.
1 www.ensembl.org/Bos_taurus, version 3.1,
release 45, www.ensembl.org
2 www.ncbi.nlm.nih.gov/BLAST
3 http://biotools.umassmed.edu
4 http://align.genome.jp
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from bovine PBMC cDNA, but our full-length
MR1 sequence had different leader and cyto-
plasmic tail sequences from the predicted En-
sembl transcript. The leader and cytoplasmic
tail sequences that we cloned were supported
by (partial) EST sequences, suggesting that
the Ensembl predicted splice sites were
incorrect.
Full-length ovine MR1 cDNA was obtained
as a clone from a PCR product obtained using
primers designed from partial bovine MR1
EST sequences applied to ovine PBMC cDNA.
The full length bovine and ovine MR1 cDNA
sequences that we obtained are available at
www.ncbi.nlm.nih.gov under accession num-
bers FJ028657 and FJ423039 and shown in
Supplementary Figure 2.
The intron/exon structure and the nucleotide
sequences of bovine and ovine full-length MR1
transcripts show a high level of similarity to
murine and human full-length ‘‘A’’ transcripts
[14]. Like in humans and mice [14, 23], the
ruminant genes have unusually long introns.
The a1a n da2 domains of bovine MR1 show
81% and 85% identity to murine and human
MR1 respectively at the amino acid level
(Fig. 1); the murine and human sequences are
90% identical. This compares with 73% identity
for the corresponding domains of bovine and
human CD1b, and 61% for murine and human
CD1d. A detailed comparison of individual
domains of the bovine and ovine MR1
sequences is given in Table I.
3.2. Alternatively spliced variants
of MR1 in cattle and sheep
Analysis of PCR products obtained from
bovine and ovine PBMC using primers
designed to generate full-length sequences of
MR1 revealed a prominent band of approxi-
mately 900 bp in addition to the band of the
predicted size of the full length product of
approximately 1100 bp. An additional band
of about 550 bp was detected in the bovine
PCR product (Fig. 2A, upper panel). Sequenc-
ing of these products demonstrated that they
represent splice variants, named boMR1.900,
boMR1.550, and ovMR1.900 (accession num-
bers FJ423041, FJ423042, FJ423040), from
which either the complete a1 (boMR1.900,
ovMR1.900), or a1a n da3 (boMR1.550) exons
are missing (Fig. 2B). These sequences did not
contain internal stop codons and retained the
original reading frame. Hence, they potentially
can generate truncated forms of the MR1 pro-
tein. Application of this PCR to cDNA from a
variety of Theileria spp.-immortalized cell-lines
of T and B lymphocyte lineage and monocyte
lineage demonstrated that the 1100 bp full
length transcript and the 900 bp splice variant
were both abundant in all of the lines
(Fig. 2A, lower panel).
3.3. MR1 protein expression is not detectable
in vivo as determined by ﬂow cytometry
Full-length bovine MR1 cDNA was cloned
i n t op c D N A 3 . 1a n du s e df o rt r a n s i e n tt r a n s f e c -
tion of HEK 293 T cells, COS-7 cells, and the
bovine macrophage cell line Bomac. A panel
of monoclonal antibodies speciﬁc for human
MR1 was tested for reactivity against bovine
MR1. Only the anti-human MR1 antibody
clone 20 recognized bovine MR1. Using a pro-
tocol that stains intracellular plus cell surface
molecules, a low percentage of cells positively
staining with clone 20 was observed among
the transfected cells (Figs. 3A–3C). No cell sur-
face expression of bovine MR1 could be
detected on the transfected cells (data not
shown). Additional monoclonal antibodies spe-
ciﬁc for classical bovine MHC class I (IL-A19),
bovine CD1 (20.27 and SBUT6) [8, 21]a n da n
unidentiﬁed bovine class I-like molecule
(CC43) [4, 21] were tested for cross-reactivity
with bovine MR1 using the protocol for intra-
cellular plus cell surface staining, and did not
stain bovine MR1 (data not shown).
Flow cytometric analyses were performed
on freshly isolated bovine PBMC, and cell sus-
pensions obtained from thymus, lymph node,
ileum and colon (data not shown), and spleen
(Figs. 3D–3F). Using the anti-human MR1 anti-
body clone 20 followed by Alexa633-labelled
goat anti-mouse in a staining protocol for intra-
cellular plus cell surface molecules, no MR1
expression was detected in spleen. As a positive
Ruminant MR1 and MAIT cells Vet. Res. (2010) 41:62
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against bovine CD3 was used. In separate
experiments, PBMC were double stained with
anti-human MR1 antibody clone 20 in combi-
nation with antibodies against CD3, CD14,
and CD21 using a protocol that stains intracel-
lular plus cell surface molecules (Figs. 3G–3I).
No expression of MR1 could be detected in any
of the cell populations, despite detection of spe-
ciﬁc staining of MR1-transfected cells using the
same staining method (Figs. 3A–3C). It should
be noted however that the sensitivity of the
staining may not have been sufﬁcient to detect
very low levels of MR1 expression.
3.4. Sequence of the bovine
and ovine MAIT cell TCR
Primer I, speciﬁc for the V segment that is
used by bovine MAITcells [13, 18] and primer
K, speciﬁc for the a constant gene segment,
respectively, were used to generate a full-length
TCRa chain PCR product from cDNA prepared
Figure 1. Alignment of MR1 sequences from different species. Alignment of full-length bovine (bo)
(accession number FJ028657.1), ovine (ov) (FJ423039), human (hu) (AJ249778.1), and murine (mu)
(AF010448.1) MR1. (*) Indicates a position with a fully conserved residue, (:) indicates strong
conservation, and(.) indicates weak conservation.
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from this PCR product revealed sequences that
were identicalorhighlysimilar tothe previously
describedbovineMAITcellTCRsequence[18].
The sequences included two variants with single
amino acid substitutions (CVVMDGNYQWI
and CVVIDGNYQWI) at position 4 in the
CDR3 region. Analysis of a further 7 cDNA
clones obtained from PBMC of a second animal
identiﬁed 3 MAIT TCRa chain sequences. The
remaining 4 clones also contained the MAIT
Va segment, but they had different CDR3 and
J gene sequences.
Ovine MAIT TCRa sequences were
obtained from PBMC by PCR using a primer
l o c a t e di nt h e5 0 untranslated region of bovine
sequences containing the MAIT Va, along with
a reverse primer in the ovine TCRa constant
region. Sequencing of 7 cloned cDNA from
the PCR product identiﬁed 2 clones with
α1 Leader T.M. Cyt. Tail
MR1 Splice Variants - bovine 
bMR1  - 1100 bp
bMR1 - 900 bp (missing α1)
MR1 Splice Variants - ovine
α3 α2
oMR1 - 900 bp (missing α1)
bMR1 - 550 bp (missing α1, α3)
oMR1  - 1100 bp
(a) (b) bo ov
1000 bp -
500 bp -
650 bp -
850 bp -
400 bp -
1650 bp -
1000 bp -
850 bp -
1650 bp -
B M BM T T T
Figure 2. Detection of MR1 splice variants. (a) Agarose gel showing bands representing different splice
variants of MR1 detected via PCR on cDNA from bovine and ovine PBMC (upper panel) and a variety of
ovine Theileria-infected cell-lines (lower panel): two B-cell lines (B), two monocyte lines (M), and three
T-cell lines (T). (b) Structure of MR1 splice variants detected in bovine and ovine PBMC. The a2 region is
preserved in all variants identiﬁed.
Table I. Cross-species comparison of MR1 nucleotide sequence. Comparison of ovine (Ov), bovine (Bo),
murine (Mu), and human (Hu) MR1 sequences show a high percentage identity when a1, a2 and a3
domains are compared across species.
Sequences
compared
Leader
(55 bp)
in %
a1
(261 bp)
in %
a2
(276 bp)
in %
a3
(276 bp)
in %
TM
(< 105 bp)
in %
Cyt
(> 40 bp)
in %
Ov:Bo 100 97 95 96 94 95
Ov:Mu 76 79 86 75 58 55
Ov:Hu 82 84 88 83 79 75
Bo:Mu 76 78 86 76 58 58
Bo:Hu 82 83 88 84 80 73
Hu:Mu 73 86 87 82 64 65
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full-length bovine MAIT sequence. The Va
sequence in these cDNA showed 96% similar-
ity with bovine MAIT Va. The J region of
these clones showed three single nucleotide dif-
ferences compared with bovine, all resulting in
coding changes; two of these differences were
in the CDR3 and resulted in amino acid substi-
tutions at positions 10 and 11 of the predicted
CDR3 sequence (CAVMDGNYRLI rather than
CAVMDGNYQWI). Based on the high level of
sequence similarity with the bovine MAIT
TCRa, we concluded that these sequences
represented ovine MAIT TCRa. The remaining
5 cDNA obtained from the original PCR con-
tained the same V gene but had different
CDR3 region sequences including different
J segments. Thus, in both species, a substantial
proportion of T cells expressing the MAIT V
segment orthologue have the invariant MAIT
TCRa chain.
Alignment of the bovine, ovine, murine and
human MAIT cell Va segment and CDR3a
shows that the CDR1 and CDR2 region
sequences in all 4 species are identical except
for one amino acid substitution in the murine
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Figure 3. Flow cytometric detection of MR1. 293Tcells were transfected with boMR1 or mock-transfected
and stained with a panel of anti human MR1 antibodies. Monoclonal antibody clone 20 stained transfected
cells (B), but not mock-transfected cells (A). Isotype-matched clone 1 did not stain transfected cells (C).
Ex vivo cell suspensions from spleen (D–F), thymus, ileum, colon and prescapular lymph node (not shown)
were stained with anti MR1 clone 20 or with anti bovine CD3. Ex vivo bovine PBMC were double stained
with anti MR1 clone 20 and anti bovine CD3, CD14 or CD21 (G–I). All stainings were performed using
a protocol that stains intracellular plus cell surface molecules.
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only one or two amino acids (Fig. 4).
3.5. Relative abundance of MAIT cells in the
total ab T cell pool of different tissues
We compared the relative transcription of the
MAIT TCRa chain to the total pool of a chains
in cell suspensions from peripheral blood,
peripheral lymph node, ileum, colon, thymus
and spleen, as well as mesenteric lymph node
in some experiments. For this purpose, we used
two qPCR reactions; one to estimate the num-
ber of constant a chains per tissue sample and
the second to estimate the number of MAIT
TCRa chains in the same sample. One of the
aforementioned full-length (bovine or ovine,
as appropriate) MAIT cell TCRa chain clones
was used to generate a standard curve for each
reaction. All experimental reactions for stan-
dards and samples were performed in triplicate.
Initial experiments were performed upon two
3-month old calves and two 6-month old sheep,
and for each animal the qPCR experiment was
performed on 2 or 3 independent occasions.
Results are presented in Figure 5. The estimated
percentages of MAIT cells within each organ,
based on relative abundance of the speciﬁc
TCRa transcripts were similar between the
pairs of calves and sheep, as well as for each
individual experimental run. In calves the high-
est percentages of MAIT cells (roughly 1–3%)
were found in spleen and ileum. All other tis-
sues showed comparatively lower MAIT cell
levels. The two sheep showed the highest per-
centages of MAIT cells (0.3–0.5%) in prescap-
ular lymph node, spleen and ileum, while the
levels in thymus, colon and PBMC were
all < 0.1%. Comparison of the two species
shows notably higher percentages in general
in cattle. With the exception of the prescapular
lymph node, the tissue preference of MAIT
cells is similar when the two different species
are compared: MAIT cells are more abundant
in spleen and ileum, and less so in thymus,
colon and PBMC.
3.6. Effect of age upon the prevalence
and distribution of MAIT cells
To determine the effect of age upon MAIT
cell prevalence and distribution we used the
above qPCR reaction to study the relative tran-
s c r i p t i o no fM A I TT C R a chain to the total pool
of a chains in tissues from calves of different
ages within the ﬁrst 3-months of life. Three
neonatal calves, three 3-week old calves, and
three 3-month old calves were used. Blood
samples from the 3-week old calves were also
collected on the day of birth to allow animal-
speciﬁc comparison of MAIT cell levels within
peripheral blood. Results are presented in
Figure 6. Neonatal animals showed consistently
low levels of MAIT cells throughout all tissues
tested, and statistical analysis of experimental
data shows a highly signiﬁcant increase in
MAIT cell abundance in 3-week (p < 0.001)
and 3-month (p = 0.044) animals when com-
pared to neonates. In particular, spleen and mes-
enteric lymph node show marked increases in
MAIT expression by 3-weeks of age, while
ileum, colon, PBMC and peripheral lymph
node showed less pronounced increases. The
increased MAIT cell abundance for each organ
appears to be maintained at this level in the
3-month old animals. By contrast, MAIT levels
remained minimal within the thymus irrespec-
tive of age. Statistical analysis of these data
showed MAIT cell levels in the spleen to be
highly signiﬁcantly raised when compared to
bovine       KGVKQPTELMAIEGASAQVNCTYQTSGFNGLFWYQQHDGGAPVFLSYNVLDGLETRGHFSSFLRRSDAHSYLLLKELHMKDFASYLCVVMDGNYQWIWGSGTKLIIK
ovine        KGVEQPTELTVMEGASAQVNCTYQTSGFNGLFWYQRHDGGAPVFLSYNVLDGLETRGHFSSFLRRSDAHSYLLLKELHMKDFASYLCAVMDGNYRLIWGSGTKLIIK
human QNIDQPTEMTATEGAIVQINCTYQTSGFNGLFWYQQHAGEAPTFLSYNVLDGLEEKGRFSSFLSRSKGYSYLLLKELQMKDSASYLCAVKDSNYQLIWGAGTKLIIK
murine       QGVEQPAKLMSVEGTFARVNCTYSTSGFNGLSWYQQREGQAPVFLSYVVLDGLKDSGHFSTFLSRSNGYSYLLLTELQIKDSASYLCAVRDSNYQLIWGSGTKLIIK
consensus CDRs TSGFNG NVLDG MDGNYQLIWG
CDR1 CDR3 CDR2
Figure 4. Comparison of MAIT TCRVa chain CDR. Alignment of the predicted amino acid sequences of
the V segment and CDR regions (grey boxes) of the MAIT TCRa chain from cattle, sheep, humans and
mouse.
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Figure 5. Estimated numbers of MAIT cells within the T cell populations in tissues of cattle and sheep.
Samples of cDNA prepared from bovine and ovine tissues were analysed by qPCR to determine the number
of MAIT cell TCRa chain transcripts and the number of a chain constant segment transcripts present.
Numbers of transcripts were calculated by comparison with a standard curve that was generated using
a cloned full-length MAIT cell a chain. Results are presented as quantities of MAIT TCRa chain expressed
as a percentage of total a chain transcripts. Each experiment was performed three times on the same tissues
from each animal. Per LN: peripheral lymph node; Mes LN: mesenteric lymph node; SI wall: small
intestinal wall; LI wall: large intestinal wall.
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peripheral lymph node (p = 0.001). Percentages
of MAITcells in mesenteric lymph node, ileum
and colon were highly signiﬁcantly increased in
comparison to thymus (p <0 . 0 0 1 ,p <0 . 0 0 1 ,
p = 0.002) and signiﬁcantly increased in com-
parison to PBMC (p = 0.016, p =0 . 0 1 5 ,
p =0 . 0 4 1 ) .
4. DISCUSSION
Human and murine MAIT cells express an
invariant TCRa chain incorporating the orthol-
ogous Vand J gene segments and near identical
CDR3 region sequences. MAIT cells are
thought to be restricted by the MHC class I-like
molecule MR1 because the development of
MAIT cells in mice is dependent on the pres-
ence of the gene for MR1, and MAIT cell
hybridomas recognize MR1 in vitro. The high
level of homology between the murine, human,
bovine, and ovine MR1 and MAIT TCRa chain
sequence that we describe here conﬁrms the
evolutionary conservation of the MR1/MAIT
system between these species.
We have furthermore demonstrated that, as
in humans and mice, MR1 protein expression
in ruminants is not detectable by ﬂow cytome-
try in cells harvested ex vivo. In the current
study, a monoclonal antibody raised against
human MR1 was used that, based on analysis
of cells transfected with bovine MR1 cDNA,
was shown to cross-react with the bovine pro-
tein. Only intracellular expression of MR1
was detected on transfectant cells, and the anti-
body did not give any intracellular or surface
staining of bovine cells harvested ex vivo. This
result may reﬂect absence of MR1 protein
expression in vivo, which may be strictly regu-
lated, but it is also possible that there is MR1
expression in vivo at a level below our detec-
tion limit. Low sensitivity of our staining
method may be due to lower afﬁnity of the anti-
body for bovine MR1 compared to human
MR1. This apparent lack of detectable protein
expression in vivo suggests that in addition to
being structurally highly homologous to the
murine and human, the MR1/MAITcell system
is also functionally highly conserved.
A remarkable feature of the analysis of MR1
transcripts in both cattle and sheep was the
0.0
1.0
2.0
3.0
4.0
Thymus Per LN Mes LN Spleen SI wall LI wall PBMC
R
e
l
a
t
i
v
e
 
A
b
u
n
d
a
n
c
e
 
o
f
 
M
A
I
T
 
T
C
R
 
(
%
)
Neonatal
3-week old
3-month old
Figure 6. Effect of age on MAIT cell abundance. Abundance of MAIT cell TCRa chain transcripts per
constant region transcripts was measured by qPCR in tissues from calves of three different age groups:
neonatal, 3-week old and 3-month old. Results are presented as quantities of MAIT TCRa expressed as
a percentage of total a chain transcripts, and represent the mean of three identical reactions run for each tissue
sample. Mesentericlymphnodes werenotassessed intwooutof three3-monthold.PerLN: peripherallymph
node; Mes LN: mesenteric lymph node; SI wall: small intestinal wall; LI wall: large intestinal wall.
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lacking the a1 exon, which was abundant both
in PBMC and in several bovine cell lines
(Fig. 2). A less abundant transcript, which
lacked both the a1a n da3 domains, was also
identiﬁed in cattle. Both variants retained the
original reading frame and would be predicted
to encode polypeptides with intact transmem-
brane and cytoplasmic domains. A number of
alternatively spliced variants of MR1 have also
been described in humans and mice [14].
Although many of the splice variants in the
mouse also had disrupted a1 domains these
mouse variants retained a small part of the a1
exon. By contrast, the human MR1 variants
most frequently exhibited in-frame truncation
of the a3e x o n .
Quantitative PCR analysis using primers
speciﬁc for MAIT TCRVaand CDR3, together
with an independent PCR for total TCRa chain
transcripts, was used in the current study to esti-
mate the relative abundance of MAIT cells in
different tissues. This provided estimates of
MAIT TCR usage in 1–2% of all ab Tc e l l s
in those tissues in which transcripts were most
abundant. These percentages are far in excess
of what can be expected for sequences gener-
ated by random rearrangement. Very low levels
of MAIT transcripts were detected in the thy-
muses of calves of different ages and in all tis-
sues of neonatal calves. A marked and
statistically signiﬁcant increase in transcripts
in certain peripheral tissues was observed in
3-week old animals. These ﬁndings are consis-
tent with observations in mice indicating that
extrathymic expansion of this population occurs
post-natally. Initial studies failed to detect
MAIT cells in human or murine thymus using
a highly-sensitive RT-PCR [18]. More recently,
Martin et al. [9] have demonstrated that MAIT
cells are positively selected within the thymus
in an MR1-dependent manner but undergo
expansion in the periphery. The latter has been
shown to be dependent on the presence of
B-cells and an intact intestinal bacterial ﬂora.
In comparison to thymus and PBMC, signif-
icantly increased levels of MAIT TCRa
chain transcripts were detectable in samples of
small intestine and mesenteric lymph nodes of
3-week and 3-month old calves. However,
transcripts were found most consistently and
most abundantly in the spleen. This is the ﬁrst
evidence that MAITcells represent a prominent
T cell population in the spleen, as there are no
comparable data on MAITcell TCR expression
in human or murine spleen. Our ﬁndings raise
questions concerning the role of the gut as a site
of expansion of these cells. The ﬁnding that
expansion of the MAIT cell population in mice
is dependent on gut ﬂora has prompted the sug-
gestion that a microbe-derived MR1-presented
ligand may cause local MAIT cell expansion
[20]. Alternatively, the primary role of the gut
ﬂora may be to activate and expand B cell pop-
ulations, which then migrate to other systemic
lymphoid tissues including the spleen, where
they can stimulate expansion of MAITcell pop-
ulations. In this model, the abundance of MAIT
cells in the bovine spleen may reﬂect the fact
that this tissue is relatively rich in B cells and
has numerous active germinal centers [10].
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